The Spaniards have one last Grand Slam ahead of them to get rid of a weak year
It was not a good season for Paula Badosa and Garbiñe Muguruza at the Grand Slams. In the case of the Spanish-Venezuelan, it was even disastrous. The pupil of Conchita Martínez barely won a match in the three tournaments played and was already in the distant Australian Open. For the first time in his career he fell on his debut at Roland Garros and Wimbledon and here, at the US Open, he has the chance to make up for a very gray season.
The problem is, historically this is the Grand Slam he is worst at. Here he has barely made it to the round of 16 twice (2017 and 2019) and there he has fewer wins, just ten in nine appearances. A demanding draw, with up to six Grand Slam winners on her side, does not inspire the optimism of a Muguruza who has won just three games at the track since April. Her chances of defending the master’s title in Los Angeles lie in winning the tournament in New York. He has no other position appearing outside of the best 50 of the season at the moment.
Badosa has also not had a quiet campaign and while there have been signs of improvement in San Jose, where she reached the semi-finals, the defeats on her debut in Toronto and Cincinnati raise the doubts of a tennis player looking to fight for the Grand Slams. this year after being crowned at Indian Wells in 2021.
His room for improvement in New York is big, as he only made it to the second round here last season. In fact, he barely won a match in his three appearances at the US Open, but it wasn’t until 2021 that he really started making regular rounds at these tournaments. In Flushing Meadows Badosa, you also play to be in Los Angeles. The Catalan is eighth in the standings, with five tennis players just 100 points to catch her.
Source: La Verdad
I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.
